Combined treatment with L-carnitine and nicotinamide riboside attenuates obesity and hepatic steatosis and reverses high-fat diet-induced disease pathways in the liver

Kanita Salic; E. Gart; Lars Verschuren; Kari E. Wong; Ivana Bobeldijk-Pastorova; P.Y. Wielinga; Robert Kleemann

Combined treatment with L-carnitine and nicotinamide riboside attenuates obesity and hepatic steatosis and reverses high-fat diet-induced disease pathways in the liver

Kanita Salic, E. Gart, Lars Verschuren, Kari E. Wong, Ivana Bobeldijk-Pastorova, P.Y. Wielinga, Robert Kleemann

Human and Animal Physiology

Research output: Contribution to conference › Poster › Academic

Original language	English
Publication status	Published - 14 May 2019
Event	Muscle Clocks and Diabetes Symposium 2019 - Amsterdam, Netherlands Duration: 14 May 2019 → 16 May 2019

Conference/symposium

Conference/symposium	Muscle Clocks and Diabetes Symposium 2019
Country/Territory	Netherlands
City	Amsterdam
Period	14/05/19 → 16/05/19

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Salic, K., Gart, E., Verschuren, L., Wong, K. E., Bobeldijk-Pastorova, I., Wielinga, P. Y., & Kleemann, R. (2019). Combined treatment with L-carnitine and nicotinamide riboside attenuates obesity and hepatic steatosis and reverses high-fat diet-induced disease pathways in the liver. Poster session presented at Muscle Clocks and Diabetes Symposium 2019, Amsterdam, Netherlands.

@conference{fd0f2fd05570443fa712f9276d9caf71,

title = "Combined treatment with L-carnitine and nicotinamide riboside attenuates obesity and hepatic steatosis and reverses high-fat diet-induced disease pathways in the liver",

author = "Kanita Salic and E. Gart and Lars Verschuren and Wong, {Kari E.} and Ivana Bobeldijk-Pastorova and P.Y. Wielinga and Robert Kleemann",

year = "2019",

month = may,

day = "14",

language = "English",

note = "Muscle Clocks and Diabetes Symposium 2019 ; Conference date: 14-05-2019 Through 16-05-2019",

}

Combined treatment with L-carnitine and nicotinamide riboside attenuates obesity and hepatic steatosis and reverses high-fat diet-induced disease pathways in the liver. / Salic, Kanita; Gart, E.; Verschuren, Lars et al.
2019. Poster session presented at Muscle Clocks and Diabetes Symposium 2019, Amsterdam, Netherlands.

Research output: Contribution to conference › Poster › Academic

TY - CONF

T1 - Combined treatment with L-carnitine and nicotinamide riboside attenuates obesity and hepatic steatosis and reverses high-fat diet-induced disease pathways in the liver

AU - Salic, Kanita

AU - Gart, E.

AU - Verschuren, Lars

AU - Wong, Kari E.

AU - Bobeldijk-Pastorova, Ivana

AU - Wielinga, P.Y.

AU - Kleemann, Robert

PY - 2019/5/14

Y1 - 2019/5/14

M3 - Poster

T2 - Muscle Clocks and Diabetes Symposium 2019

Y2 - 14 May 2019 through 16 May 2019

ER -